Mechanistic explanation for platelet contribution to cancer metastasis

Thrombosis Research

Volumn 133, Issue SUPPL. 2, 2014, Pages

  Stegner, David ^a   Dütting, Sebastian ^a   Nieswandt, Bernhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aggregation; Cancer; Platelet signaling; Thrombosis; Tumor metastasis

Indexed keywords

THROMBOCYTE RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER IMMUNOLOGY; CIRCULATING TUMOR CELL; EXTRAVASATION; HUMAN; IMMUNOSURVEILLANCE; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; TUMOR CELL; TUMOR EXTRAVASATION; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR EMBOLISM;

BLOOD PLATELETS; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PLATELET AGGREGATION;

EID: 84901449333     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(14)50025-4     Document Type: Article

References (151)

1. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat Rev Cancer 9 2009 239 252
2. A. Trousseau Clinique Medicale de L'Hotel-Dieu Paris 1865 New Sydenham Society London 94 96
3. T. Billroth Lectures on surgical pathology and therapeutics: A handbook for students and practitioners 8th ed. 1878 The New Syndenham Society London 335
4. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1968 46 52
5. E. Sierko, and M.Z. Wojtukiewicz Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost 33 2007 712 721 (Pubitemid 350157017)
6. K.V. Honn, D.G. Tang, and J.D. Crissman Platelets and cancer metastasis: A causal relationship? Cancer Metastasis Rev 11 1992 325 351
7. A.G. Zeimet, C. Marth, E. Muller-Holzner, G. Daxenbichler, and O. Dapunt Significance of thrombocytosis in patients with epithelial ovarian cancer Am J Obstet Gynecol 170 1994 549 554 (Pubitemid 24089013)
8. F. Gucer, F. Moser, K. Tamussino, O. Reich, J. Haas, and G. Arikan et al. Thrombocytosis as a prognostic factor in endometrial carcinoma Gynecol Oncol 70 1998 210 214 (Pubitemid 28430931)
9. M. Monreal, J. Fernandez-Llamazares, M. Pinol, J.F. Julian, M. Broggi, and D. Escola et al. Platelet count and survival in patients with colorectal cancer-a preliminary study Thromb Haemost 79 1998 916 918 (Pubitemid 28224723)
10. M. Ikeda, H. Furukawa, H. Imamura, J. Shimizu, H. Ishida, and S. Masutani et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer Ann Surg Oncol 9 2002 287 291 (Pubitemid 34298634)
11. J. Gao, H.Y. Zhang, and Y.F. Xia Increased platelet count is an indicator of metastasis in patients with nasopharyngeal carcinoma Tumour Biol 34 2013 39 45
12. S. Wan, Y. Lai, R.E. Myers, B. Li, T. Hyslop, and J. London et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients J Gastrointest Cancer 44 2013 293 304
13. D. Stegner, and B. Nieswandt Platelet receptor signaling in thrombus formation J Mol Med (Berl) 89 2011 109 121
14. J.W. Heemskerk, N.J. Mattheij, and J.M. Cosemans Platelet-based coagulation: different populations, different functions J Thromb Haemost 11 2013 2 16
15. F. Müller, N. Mutch, W. Schenk, S. Smith, L. Esterl, and H. Spronk et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo Cell 139 2009 1143 1156
16. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572 (Pubitemid 37328923)
17. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
18. E. Bastida, A. Ordinas, S.L. Giardina, and G.A. Jamieson Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase Cancer Res 42 1982 4348 4352 (Pubitemid 13205923)
19. S. Pinto, L. Gori, O. Gallo, S. Boccuzzi, R. Paniccia, and R. Abbate Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx Prostaglandins Leukot Essent Fatty Acids 49 1993 527 530 (Pubitemid 23198220)
20. M. Zucchella, L. Dezza, L. Pacchiarini, F. Meloni, F. Tacconi, and E. Bonomi et al. Human tumor cells cultured "in vitro" activate platelet function by producing ADP or thrombin Haematologica 74 1989 541 545 (Pubitemid 20095903)
21. G. Grignani, L. Pacchiarini, M.M. Ricetti, P. Dionigi, V. Jemos, and M. Zucchella et al. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues Invasion Metastasis 9 1989 298 309 (Pubitemid 19204261)
22. A.B. Malik Pulmonary microembolism Physiol Rev 63 1983 1114 1207 (Pubitemid 13048721)
23. V. Abbasciano, M.P. Bianchi, L. Trevisani, S. Sartori, G. Gilli, and G. Zavagli Platelet activation and fibrinolysis in large bowel cancer Oncology 52 1995 381 384
24. J.P. Ferriere, D. Bernard, M. Legros, J. Chassagne, P. Chollet, and G. Gaillard et al. beta-Thromboglobulin in patients with breast cancer Am J Hematol 19 1985 47 53
25. R. Milroy, J.T. Douglas, J. Campbell, R. Carter, G.D. Lowe, and S.W. Banham Abnormal haemostasis in small cell lung cancer Thorax 43 1988 978 981 (Pubitemid 19023760)
26. D. Prisco, R. Paniccia, M. Coppo, M. Filippini, I. Francalanci, and T. Brunelli et al. Platelet activation and platelet lipid composition in pulmonary cancer Prostaglandins Leukot Essent Fatty Acids 53 1995 65 68
27. T. Yazaki, H. Inage, T. Iizumi, A. Koyama, S. Kanoh, and K. Koiso et al. Studies on platelet function in patients with prostatic cancer Preliminary report. Urology 30 1987 60 63 (Pubitemid 17092293)
28. S. Karpatkin, E. Pearlstein, C. Ambrogio, and B.S. Coller Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo J Clin Invest 81 1988 1012 1019
29. S. Dutting, M. Bender, and B. Nieswandt Platelet GPVI: A target for antithrombotic therapy?! Trends Pharmacol Sci 33 2012 583 590
30. E. Bastida, L. Almirall, and A. Ordinas Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipoxygenase-associated process Int J Cancer 39 1987 760 763 (Pubitemid 17087878)
31. I.M. Grossi, L.A. Fitzgerald, A. Kendall, J.D. Taylor, B.F. Sloane, and K.V. Honn Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa Proc Soc Exp Biol Med 186 1987 378 383 (Pubitemid 18055368)
32. L. Erpenbeck, B. Nieswandt, M. Schön, M. Pozgajova, and M. Schon Inhibition of platelet GPIb alpha and promotion of melanoma metastasis J Invest Dermatol 130 2010 576 586
33. S. Jain, M. Zuka, J. Liu, S. Russell, J. Dent, and J.A. Guerrero et al. Platelet glycoprotein Ib alpha supports experimental lung metastasis Proc Natl Acad Sci U S A 104 2007 9024 9028 (Pubitemid 47175430)
34. V. Terraube, I. Marx, and C.V. Denis Role of von Willebrand factor in tumor metastasis Thromb Res 120 Suppl 2 2007 S64 S70
35. C.V. Denis, P. Andre, S. Saffaripour, and D.D. Wagner Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice Proc Natl Acad Sci U S A 98 2001 4072 4077 (Pubitemid 32249900)
36. Y.J. Kim, L. Borsig, N.M. Varki, and A. Varki P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci U S A 95 1998 9325 9330 (Pubitemid 28506230)
37. R.J. Ludwig, B. Boehme, M. Podda, R. Henschler, E. Jager, and C. Tandi et al. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2004 2743 2750 (Pubitemid 38500611)
38. L.A. Coupland, B.H. Chong, and C.R. Parish Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells Cancer Res 72 2012 4662 4671
39. S. Jain, J. Harris, and J. Ware Platelets: linking hemostasis and cancer Arterioscler Thromb Vasc Biol 30 2010 2362 2367
40. F. May, I. Hagedorn, I. Pleines, M. Bender, T. Vogtle, and J. Eble et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis Blood 114 2009 3464 3472
41. K. Suzuki-Inoue, Y. Kato, O. Inoue, M.K. Kaneko, K. Mishima, and Y. Yatomi et al. Involvement of the Snake Toxin Receptor CLEC-2, in Podoplanin-mediated Platelet Activation, by Cancer Cells J Biol Chem 282 2007 25993 26001 (Pubitemid 47443800)
42. N. Fujita, and S. Takagi The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis J Biochem 152 2012 407 413
43. Y. Kato, M. Kaneko, M. Sata, N. Fujita, T. Tsuruo, and M. Osawa Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma Tumour Biol 26 2005 195 200 (Pubitemid 41379745)
44. Y. Kato, M.K. Kaneko, A. Kuno, N. Uchiyama, K. Amano, and Y. Chiba et al. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain Biochem Biophys Res Commun 349 2006 1301 1307 (Pubitemid 44416399)
45. Y. Nakazawa, S. Takagi, S. Sato, T. Oh-hara, S. Koike, and M. Takami et al. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies Cancer Sci 102 2011 2051 2057
46. A. Kunita, T.G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, and T. Tsuruo et al. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 2007 1337 1347 (Pubitemid 47339340)
47. S. Takagi, S. Sato, T. Oh-hara, M. Takami, S. Koike, and Y. Mishima et al. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2 PLoS ONE 8 2013 e73609
48. V. Schacht, M.I. Ramirez, Y.K. Hong, S. Hirakawa, D. Feng, and N. Harvey et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO J 22 2003 3546 3556 (Pubitemid 36898332)
49. P. Uhrin, J. Zaujec, J.M. Breuss, D. Olcaydu, P. Chrenek, and H. Stockinger et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation Blood 115 2010 3997 4005
50. B.H. Herzog, J. Fu, S.J. Wilson, P.R. Hess, A. Sen, and J.M. McDaniel et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2 Nature 502 2013 105 109
51. P.R. Hess, D.R. Rawnsley, Z. Jakus, Y. Yang, D.T. Sweet, and J. Fu et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life J Clin Invest 124 2014 273 284
52. S. Murugappa, and S.P. Kunapuli The role of ADP receptors in platelet function Front Biosci 11 2006 1977 1986 (Pubitemid 43253409)
53. E. Bastida, and A. Ordinas Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation Haemostasis 18 1988 29 36
54. H. Boukerche, O. Berthier-Vergnes, F. Penin, E. Tabone, G. Lizard, and M. Bailly et al. Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets Br J Haematol 87 1994 763 772 (Pubitemid 24264649)
55. Y. Wang, Y. Sun, D. Li, L. Zhang, K. Wang, and Y. Zuo et al. Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis PLoS ONE 8 2013 e80780
56. D. Schumacher, B. Strilic, K.K. Sivaraj, N. Wettschureck, and S. Offermanns Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor Cancer Cell 24 2013 130 137
57. M.Z. Wojtukiewicz, L.R. Zacharski, V.A. Memoli, W. Kisiel, B.J. Kudryk, and S.M. Rousseau et al. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ Am J Clin Pathol 93 1990 516 521 (Pubitemid 20128848)
58. K. Hamada, J. Kuratsu, Y. Saitoh, H. Takeshima, T. Nishi, and Y. Ushio Expression of tissue factor correlates with grade of malignancy in human glioma Cancer 77 1996 1877 1883 (Pubitemid 26125190)
59. M. Sawada, S. Miyake, S. Ohdama, O. Matsubara, S. Masuda, and K. Yakumaru et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis Br J Cancer 79 1999 472 477 (Pubitemid 29046221)
60. S. Seto, H. Onodera, T. Kaido, A. Yoshikawa, S. Ishigami, and S. Arii et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis Cancer 88 2000 295 301 (Pubitemid 30051812)
61. E. Camerer, A.A. Qazi, D.N. Duong, I. Cornelissen, R. Advincula, and S.R. Coughlin Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 104 2004 397 401 (Pubitemid 38900020)
62. G.R. Sambrano, E.J. Weiss, Y.W. Zheng, W. Huang, and S.R. Coughlin Role of thrombin signalling in platelets in haemostasis and thrombosis Nature 413 2001 74 78 (Pubitemid 32843490)
63. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, and K.W. Kombrinck et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 2005 178 185 (Pubitemid 40053080)
64. B. Nieswandt, D. Varga-Szabo, and M. Elvers Integrins in platelet activation J Thromb Haemost 7 Suppl 1 2009 206 209
65. M.J. Humphries, K. Olden, and K.M. Yamada A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells Science 233 1986 467 470 (Pubitemid 16046307)
66. I. Saiki, J. Murata, J. Iida, T. Sakurai, N. Nishi, and K. Matsuno et al. Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences Br J Cancer 60 1989 722 728 (Pubitemid 19275738)
67. A. Amirkhosravi, S.A. Mousa, M. Amaya, S. Blaydes, H. Desai, and T. Meyer et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 Thromb Haemost 90 2003 549 554 (Pubitemid 37138780)
68. S.J. Bakewell, P. Nestor, S. Prasad, M.H. Tomasson, N. Dowland, and M. Mehrotra et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis Proc Natl Acad Sci U S A 100 2003 14205 14210 (Pubitemid 37499215)
69. J.S. Palumbo, J.M. Potter, L.S. Kaplan, K. Talmage, D.G. Jackson, and J.L. Degen Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice Cancer Res 62 2002 6966 6972 (Pubitemid 35424088)
70. O. Engebraaten, M. Trikha, S. Juell, S. Garman-Vik, and O. Fodstad Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b) beta3 integrins Anticancer Res 29 2009 131 137
71. M. Trikha, Z. Zhou, J. Timar, E. Raso, M. Kennel, and E. Emmell et al. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis Cancer Res 62 2002 2824 2833 (Pubitemid 34525767)
72. E. Bastida, A. Ordinas, and G.A. Jamieson Differing platelet aggregating effects by two tumor cell lines: Absence of role for platelet-derived ADP Am J Hematol 11 1981 367 378 (Pubitemid 12248873)
73. I.J. Fidler Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine J Natl Cancer Inst 45 1970 773 782
74. L.A. Liotta Cancer cell invasion and metastasis Sci Am 266 54-9 1992 62 63
75. R.B. Herberman, M.E. Nunn, and D.H. Lavrin Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity Int J Cancer 16 1975 216 229
76. E. Vivier, S. Ugolini, D. Blaise, C. Chabannon, and L. Brossay Targeting natural killer cells and natural killer T cells in cancer Nat Rev Immunol 12 2012 239 252
77. W.J. Storkus, and J.R. Dawson Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules Crit Rev Immunol 10 1991 393 416
78. N. Hanna The role of natural killer cells in the control of tumor growth and metastasis Biochim Biophys Acta 780 1985 213 226
79. J.E. Talmadge, K.M. Meyers, D.J. Prieur, and J.R. Starkey Role of NK cells in tumour growth and metastasis in beige mice Nature 284 1980 622 624 (Pubitemid 10070870)
80. R.H. Wiltrout, R.B. Herberman, S.R. Zhang, M.A. Chirigos, J.R. Ortaldo, and K.M. Green Jr. et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver J Immunol 134 1985 4267 4275 (Pubitemid 15029660)
81. K. Imai, S. Matsuyama, S. Miyake, K. Suga, and K. Nakachi Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population Lancet 356 2000 1795 1799
82. S. Karpatkin, C. Ambrogio, and E. Pearlstein The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis Prog Clin Biol Res 283 1988 585 606
83. M. Mahalingam, K.E. Ugen, K.J. Kao, and P.A. Klein Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants Cancer Res 48 1988 1460 1464 (Pubitemid 18091189)
84. B. Nieswandt, M. Hafner, B. Echtenacher, and D.N. Mannel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1999 1295 1300 (Pubitemid 29136261)
85. M. Morowski, T. Vogtle, P. Kraft, C. Kleinschnitz, G. Stoll, and B. Nieswandt Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice Blood 121 2013 4938 4947
86. J.S. Palumbo, K.A. Barney, E.A. Blevins, M.A. Shaw, A. Mishra, and M.J. Flick et al. Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function J Thromb Haemost 6 2008 812 819 (Pubitemid 351524542)
87. H. Shau, M.D. Roth, and S.H. Golub Regulation of natural killer function by nonlymphoid cells Nat Immun 12 1993 235 249 (Pubitemid 23297442)
88. H.G. Kopp, T. Placke, and H.R. Salih Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res 69 2009 7775 7783
89. T. Placke, M. Orgel, M. Schaller, G. Jung, H.G. Rammensee, and H.G. Kopp et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells Cancer Res 72 2012 440 448
90. K. Palucka, and J. Banchereau Cancer immunotherapy via dendritic cells Nat Rev Cancer 12 2012 265 277
91. R. Mohle, D. Green, M.A. Moore, R.L. Nachman, and S. Rafii Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Proc Natl Acad Sci U S A 94 1997 663 668 (Pubitemid 27053690)
92. J.E. Ohm, and D.P. Carbone VEGF as a mediator of tumor-associated immunodeficiency Immunol Res 23 2001 263 272 (Pubitemid 32575367)
93. R. Salgado, P.B. Vermeulen, I. Benoy, R. Weytjens, P. Huget, and E. Van Marck et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients Br J Cancer 80 1999 892 897 (Pubitemid 29209856)
94. L. Yang, and D.P. Carbone Tumor-host immune interactions and dendritic cell dysfunction Adv Cancer Res 92 2004 13 27 (Pubitemid 39458111)
95. J. Timar, J. Tovari, E. Raso, L. Meszaros, B. Bereczky, and K. Lapis Platelet-mimicry of cancer cells: epiphenomenon with clinical significance Oncology 69 2005 185 201 (Pubitemid 41433577)
96. F.L. Miles, F.L. Pruitt, K.L. Van Golen, and C.R. Cooper Stepping out of the flow: capillary extravasation in cancer metastasis Clin Exp Metastasis 25 2008 305 324 (Pubitemid 351748980)
97. J.A. Coppinger, G. Cagney, S. Toomey, T. Kislinger, O. Belton, and J.P. McRedmond et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions Blood 103 2004 2096 2104 (Pubitemid 38326225)
98. S. Smyth, R. McEver, A. Weyrich, C. Morrell, M. Hoffman, and G. Arepally et al. Platelet functions beyond hemostasis J Thromb Haemost 7 2009 1759 1766
99. B. Visentin, J.A. Vekich, B.J. Sibbald, A.L. Cavalli, K.M. Moreno, and R.G. Matteo et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 9 2006 225 238 (Pubitemid 43357948)
100. M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux, and J. Ribeiro et al. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts PLoS ONE 5 2010 e9741
101. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
102. D. Marsolais, and H. Rosen Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules Nat Rev Drug Discov 8 2009 297 307
103. Y. Yatomi, T. Ohmori, G. Rile, F. Kazama, H. Okamoto, and T. Sano et al. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells Blood 96 2000 3431 3438
104. M.H. Sarker, D.E. Hu, and P.A. Fraser Regulation of cerebromicrovascular permeability by lysophosphatidic acid Microcirculation 17 2010 39 46
105. M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells Proc Natl Acad Sci U S A 100 2003 9482 9487 (Pubitemid 37033954)
106. E.I. Deryugina, and J.P. Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 2006 9 34 (Pubitemid 43723979)
107. C. Deppermann, D. Cherpokova, P. Nurden, J.N. Schulz, I. Thielmann, and P. Kraft et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2- deficient mice J Clin Invest 123 2013 3331 3342
108. W.H. Kahr, R.W. Lo, L. Li, F.G. Pluthero, H. Christensen, and R. Ni et al. Abnormal megakaryocyte development and platelet function in Nbeal2-/- mice Blood 122 2013 3349 3358
109. G.L. Reed Platelet secretory mechanisms Semin Thromb Hemost 30 2004 441 450 (Pubitemid 39180719)
110. Q. Ren, S. Ye, and S. Whiteheart The platelet release reaction: just when you thought platelet secretion was simple Curr Opin Hematol 15 2008 537 541
111. F. Cote, C. Fligny, Y. Fromes, J. Mallet, and G. Vodjdani Recent advances in understanding serotonin regulation of cardiovascular function Trends Mol Med 10 2004 232 238 (Pubitemid 38581796)
112. G. Skolnik, U. Bagge, A. Dahlstrom, and H. Ahlman The importance of 5-HT for tumor cell lodgement in the liver Int J Cancer 33 1984 519 523 (Pubitemid 14142430)
113. G. Skolnik, U. Bagge, G. Blomqvist, L. Djarv, and H. Ahlman The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver Clin Exp Metastasis 7 1989 169 174 (Pubitemid 19071381)
114. V.A. Medina, and E.S. Rivera Histamine receptors and cancer pharmacology Br J Pharmacol 161 2010 755 767
115. G. Bendas, and L. Borsig Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins Int J Cell Biol 2012 2012 676 731
116. V.S. Dole, W. Bergmeier, H.A. Mitchell, S.C. Eichenberger, and D.D. Wagner Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin Blood 106 2005 2334 2339 (Pubitemid 41510804)
117. Y. Huo, A. Schober, S. Forlow, D. Smith, M. Hyman, and S. Jung et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 2003 61 67 (Pubitemid 36098261)
118. R.J. Ludwig, J.E. Schultz, W.H. Boehncke, M. Podda, C. Tandi, and F. Krombach et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules J Invest Dermatol 122 2004 830 836 (Pubitemid 38471355)
119. S. Ferjancic, A.M. Gil-Bernabe, S.A. Hill, P.D. Allen, P. Richardson, and T. Sparey et al. VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice Blood 121 2013 3289 3297
120. B. Qian, Y. Deng, J.H. Im, R.J. Muschel, Y. Zou, and J. Li et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth PLoS ONE 4 2009 e6562
121. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
122. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
123. J. Kisucka, C.E. Butterfield, D.G. Duda, S.C. Eichenberger, S. Saffaripour, and J. Ware et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Proc Natl Acad Sci U S A 103 2006 855 860 (Pubitemid 43212187)
124. E. Pipili-Synetos, E. Papadimitriou, and M.E. Maragoudakis Evidence that platelets promote tube formation by endothelial cells on matrigel Br J Pharmacol 125 1998 1252 1257 (Pubitemid 28542534)
125. J.S. Rhee, M. Black, U. Schubert, S. Fischer, E. Morgenstern, and H.P. Hammes et al. The functional role of blood platelet components in angiogenesis Thromb Haemost 92 2004 394 402 (Pubitemid 39177413)
126. H.M. Verheul, A.S. Jorna, K. Hoekman, H.J. Broxterman, M.F. Gebbink, and H.M. Pinedo Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets Blood 96 2000 4216 4221
127. J.E. Italiano Jr., J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, and S. Short et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 2008 1227 1233 (Pubitemid 351213404)
128. L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, and M.D. Hollenberg et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci U S A 102 2005 216 220 (Pubitemid 40094455)
129. E.M. Battinelli, B.A. Markens, R.A. Kulenthirarajan, K.R. Machlus, R. Flaumenhaft, and J.E. Italiano Jr. Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response Blood 123 2014 101 112
130. H.M. Verheul, K. Hoekman, S. Luykx-de Bakker, C.A. Eekman, C.C. Folman, and H.J. Broxterman et al. Platelet: transporter of vascular endothelial growth factor Clin Cancer Res 3 1997 2187 2190 (Pubitemid 28133134)
131. U. Wartiovaara, V. Joukov, H. Mikkola, K. Alitalo, and A. Palotie Vascular endothelial growth factor C (VEGF-C) is expressed in thrombocytes Thromb Haemost 1997 3018
132. G. McDowell, I. Temple, C. Li, C.C. Kirwan, N.J. Bundred, and C.N. McCollum et al. Alteration in platelet function in patients with early breast cancer Anticancer Res 25 2005 3963 3966 (Pubitemid 41665170)
133. T.A. Brock, H.F. Dvorak, and D.R. Senger Tumor-secreted vascular permeability factor increases cytosolic Ca2 + and von Willebrand factor release in human endothelial cells Am J Pathol 138 1991 213 221
134. A. Zaslavsky, K.H. Baek, R.C. Lynch, S. Short, J. Grillo, and J. Folkman et al. Plateletderived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis Blood 115 2010 4605 4613
135. E. Vivier What is natural in natural killer cells? Immunol Lett 107 2006 1 7 (Pubitemid 44332546)
136. M. Terme, E. Ullrich, N.F. Delahaye, N. Chaput, and L. Zitvogel Natural killer cell-directed therapies: moving from unexpected results to successful strategies Nat Immunol 9 2008 486 494 (Pubitemid 351560517)
137. D. Bhatt, and E. Topol Scientific and therapeutic advances in antiplatelet therapy Nat Rev Drug Discov 2 2003 15 28 (Pubitemid 37361621)
138. W. Zhang, S. Dang, T. Hong, J. Tang, J. Fan, and D. Bu et al. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment Blood 120 2012 2889 2898
139. E.M. Flahavan, K. Bennett, L. Sharp, and T.I. Barron A cohort study investigating aspirin use and survival in men with prostate cancer Ann Oncol 25 2014 154 159
140. M.S. Reimers, E. Bastiaannet, M.P. Van Herk-Sukel, V.E. Lemmens, C.B. Van den Broek, and C.J. Van de Velde et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: A retrospective cohort study J Am Geriatr Soc 60 2012 2232 2236
141. P.M. Rothwell, M. Wilson, J.F. Price, J.F. Belch, T.W. Meade, and Z. Mehta Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials Lancet 379 2012 1591 1601
142. F.M. Shebl, L.C. Sakoda, A. Black, J. Koshiol, G.L. Andriole, and R. Grubb et al. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: A PLCO study Br J Cancer 107 2012 207 214
143. T. Veitonmaki, T.L. Tammela, A. Auvinen, and T.J. Murtola Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level Eur J Cancer 49 2013 938 945
144. M.J. Thun, E.J. Jacobs, and C. Patrono The role of aspirin in cancer prevention Nat Rev Clin Oncol 9 2012 259 267
145. A.M. Gil-Bernabe, S. Lucotti, and R.J. Muschel Coagulation and metastasis: what does the experimental literature tell us? Br J Haematol 162 2013 433 441
146. S. Jain, S. Russell, and J. Ware Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models J Thromb Haemost 7 2009 1713 1717
147. L. Erpenbeck, and M. Schön Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Blood 115 2010 3427 3436
148. J.L. Stevenson, A. Varki, and L. Borsig Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects Thromb Res 120 Suppl 2 2007 S107 S111
149. C.C. Zielinski, and M. Hejna Warfarin for cancer prevention N Engl J Med 342 2000 1991 1993 (Pubitemid 30419098)
150. G.T. Gerotziafas, C. Papageorgiou, M. Hatmi, M.M. Samama, and I. Elalamy Clinical studies with anticoagulants to improve survival in cancer patients Pathophysiol Haemost Thromb 36 2008 204 211
151. C.L. Modery-Pawlowski, A.M. Master, V. Pan, G.P. Howard, and Gupta A. Sen A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms Biomacromolecules 14 2013 910 919